These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37783559)

  • 1. Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885.
    Sharma HS; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Bryukhovetskiy I; Manzhulo I; Wiklund L; Sharma A
    Int Rev Neurobiol; 2023; 171():3-46. PubMed ID: 37783559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin.
    Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Bryukhovetskiy I; Manzhulo I; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 171():125-162. PubMed ID: 37783554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide.
    Sharma HS; Muresanu DF; Castellani RJ; Nozari A; Lafuente JV; Buzoianu AD; Sahib S; Tian ZR; Bryukhovetskiy I; Manzhulo I; Menon PK; Patnaik R; Wiklund L; Sharma A
    Prog Brain Res; 2021; 265():1-97. PubMed ID: 34560919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury.
    Sharma HS; Muresanu DF; Nozari A; Lafuente JV; Buzoianu AD; Tian ZR; Huang H; Feng L; Bryukhovetskiy I; Manzhulo I; Wiklund L; Sharma A
    Adv Neurobiol; 2023; 32():139-192. PubMed ID: 37480461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation.
    Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Bryukhovetskiy I; Manzhulo I; Wiklund L; Sharma HS
    Adv Neurobiol; 2023; 32():3-53. PubMed ID: 37480458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha.
    Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 172():3-35. PubMed ID: 37833015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.
    Nozari A; Sharma A; Wang Z; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Wiklund L; Sharma HS
    Adv Neurobiol; 2023; 32():271-313. PubMed ID: 37480464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.
    Sharma HS; Muresanu DF; Lafuente JV; Patnaik R; Tian ZR; Ozkizilcik A; Castellani RJ; Mössler H; Sharma A
    Mol Neurobiol; 2018 Jan; 55(1):300-311. PubMed ID: 28844104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury.
    Wang ZG; Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Huang H; Chen L; Manzhulo I; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 172():145-185. PubMed ID: 37833011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Treatment Strategies Using TiO
    Sharma A; Menon PK; Patnaik R; Muresanu DF; Lafuente JV; Tian ZR; Ozkizilcik A; Castellani RJ; Mössler H; Sharma HS
    Int Rev Neurobiol; 2017; 137():123-165. PubMed ID: 29132541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.
    Patnaik R; Sharma A; Skaper SD; Muresanu DF; Lafuente JV; Castellani RJ; Nozari A; Sharma HS
    Mol Neurobiol; 2018 Jan; 55(1):312-321. PubMed ID: 28861757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease.
    Buzoianu AD; Sharma A; Muresanu DF; Feng L; Huang H; Chen L; Tian ZR; Nozari A; Lafuente JV; Wiklund L; Sharma HS
    Adv Neurobiol; 2023; 32():55-96. PubMed ID: 37480459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease.
    Sharma HS; Muresanu DF; Castellani RJ; Nozari A; Lafuente JV; Tian ZR; Ozkizilcik A; Manzhulo I; Mössler H; Sharma A
    Prog Brain Res; 2019; 245():145-200. PubMed ID: 30961867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease.
    Ozkizilcik A; Sharma A; Feng L; Muresanu DF; Tian ZR; Lafuente JV; Buzoianu AD; Nozari A; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 171():83-121. PubMed ID: 37783564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination as a therapeutic approach to Alzheimer's disease.
    Wisniewski T; Boutajangout A
    Mt Sinai J Med; 2010; 77(1):17-31. PubMed ID: 20101719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy.
    Sharma HS; Muresanu DF; Sharma A
    Neurodegener Dis Manag; 2016 Dec; 6(6):453-456. PubMed ID: 27827552
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50-60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron.
    Tian ZR; Sharma A; Muresanu DF; Sharma S; Feng L; Zhang Z; Li C; Buzoianu AD; Lafuente JV; Nozari A; Sjöqvisst PO; Wiklund L; Sharma HS
    Int Rev Neurobiol; 2023; 172():189-233. PubMed ID: 37833012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.
    Lathuilière A; Laversenne V; Astolfo A; Kopetzki E; Jacobsen H; Stampanoni M; Bohrmann B; Schneider BL; Aebischer P
    Brain; 2016 May; 139(Pt 5):1587-604. PubMed ID: 26956423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.